Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07308639) titled 'DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information' on Dec. 17, 2025.
Study Type: Observational
Primary Sponsor: Bayer
Condition:
Neovascular Age-related Macular Degeneration (nAMD)
Diabetic Macular Edema (DME)
Retinal Vein Occlusion (RVO)
Intervention:
Drug: anti-VEGF medication
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2026
Target Sample Size: 50000
Countries of Recruitment:
Germany
To know more, visit https://cli...